Ionis Pharmaceuticals CEO Stanley Crooke's 2018 pay rises 4% to $7.6M
Ionis Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 26, 2019
Ionis Pharmaceuticals reported fiscal year 2018 executive compensation information on April 26, 2019.
In 2018, six executives at Ionis Pharmaceuticals received on average a compensation package of $4.4M, a 20% increase compared to previous year.
Average pay of disclosed executives at Ionis Pharmaceuticals
Stanley T. Crooke, Chief Executive Officer, received $7.6M in total, which increased by 4% compared to 2017. 53% of Crooke's compensation, or $4.1M, was in option awards. Crooke also received $759K in bonus, $883K in salary, $1.9M in stock awards, as well as $39K in other compensation.
For fiscal year 2018, the median employee pay was $244,261 at Ionis Pharmaceuticals. Therefore, the ratio of Stanley T. Crooke's pay to the median employee pay was 31 to one.
B. Lynne Parshall, Chief Operating Officer, received a compensation package of $5.7M, which increased by 7% compared to previous year. 54% of the compensation package, or $3.1M, was in option awards.
Brett Monia, Chief Operating Officer, earned $4.3M in 2018, a 77% increase compared to previous year.
Richard S. Geary, Senior Vice President, Development, received $3M in 2018, which increases by 28% compared to 2017.
Patrick R. O'Neil, General Counsel, earned $2.8M in 2018, a 22% increase compared to previous year.
Elizabeth L. Hougen, Chief Financial Officer, received $2.8M in 2018, which increases by 25% compared to 2017.
Related executives
Stanley Crooke
Ionis Pharmaceuticals
Chairman
Elizabeth Hougen
Ionis Pharmaceuticals
Chief Financial Officer
Brett Monia
Ionis Pharmaceuticals
Chief Executive Officer
Richard Geary
Ionis Pharmaceuticals
Executive Vice President, Chief Development Officer
Patrick O'Neil
Ionis Pharmaceuticals
General Counsel
B Parshall
Ionis Pharmaceuticals
Chief Operating Officer
You may also like
Source: SEC filing on April 26, 2019.